STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.

Document type:: Journal Article; Letter
Author(s):: Hiller, Julia; Hagl, Beate; Effner, Renate; Puel, Anne; Schaller, Martin; Mascher, Birgit; Eyerich, Stefanie; Eyerich, Kilian; Jansson, Annette F; Ring, Johannes; Casanova, Jean-Laurent; Renner, Ellen D; Traidl-Hoffmann, Claudia
Title:: STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.
Journal title abbreviation:: J Invest Dermatol
Year:: 2018
Journal volume:: 138
Journal issue:: 3
Pages contribution:: 711-714
Language:: eng
Fulltext / DOI:: doi:10.1016/j.jid.2017.09.035
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/29054602
Print-ISSN:: 0022-202X
TUM Institution:: Klinik und Poliklinik für Dermatologie und Allergologie; Molekulare Allergologie (Prof. Schmidt-Weber); Professur für Experimentelle Dermato-Immunologie (Prof. Eyerich)
BibTeX

Occurrences: